Davide Leone & Partners Investment Co Ltd. - Q1 2020 holdings

$708 Million is the total value of Davide Leone & Partners Investment Co Ltd.'s 16 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 100.0% .

 Value Shares↓ Weighting
VRTX ExitVERTEX PHARMACEUTICALS INC$0-124,358
-100.0%
-3.50%
INCY ExitINCYTE CORP$0-373,387
-100.0%
-4.18%
QGEN ExitQIAGEN NV$0-1,010,107
-100.0%
-4.38%
ZAYO ExitZAYO GROUP HLDGS INC$0-1,365,744
-100.0%
-6.07%
TIF ExitTIFFANY & CO NEW$0-571,312
-100.0%
-9.80%
MDCO ExitMEDICINES COcall$0-1,000,000
-100.0%
-10.90%
T ExitAT&T INC$0-2,256,331
-100.0%
-11.32%
MDCO ExitMEDICINES CO$0-1,146,192
-100.0%
-12.50%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-05-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
BERKSHIRE HATHAWAY INC DEL19Q3 20237.8%
ACADIA HEALTHCARE COMPANY IN9Q4 202114.1%
BLACKBERRY LTD9Q4 202110.1%
ILLUMINA INC8Q4 20208.8%
ENCOMPASS HEALTH CORP7Q2 202298.2%
INCYTE CORP6Q1 20215.0%
AMERICAN WELL CORP6Q4 20212.7%
BIOMARIN PHARMACEUTICAL INC5Q3 20219.1%
VONTIER CORPORATION5Q4 20219.9%
QIAGEN NV5Q1 20217.7%

View Davide Leone & Partners Investment Co Ltd.'s complete holdings history.

Latest filings
TypeFiled
13F-HR2024-05-15
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14

View Davide Leone & Partners Investment Co Ltd.'s complete filings history.

Compare quarters

Export Davide Leone & Partners Investment Co Ltd.'s holdings